CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high value healthcare solutions for transplant patients and caregivers, reported financial results for the fourth quarter and full year ended December 31, 2019.
February 27, 2020
· 14 min read